Investigational Site Number : 3800002

Rome, Lazio 00168

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Chronic Rhinosinusitis With Nasal Polyps, Transplant Rejection

Studies at this site

• BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR) — Running, not enrolling
• Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — Completed
• EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients — Completed